Yuchen Wang Selected Research

Type 2 Diabetes Mellitus (MODY)

1/2021	Artesunate Combined With Metformin Ameliorate on Diabetes-Induced Xerostomia by Mitigating Superior Salivatory Nucleus and Salivary Glands Injury in Type 2 Diabetic Rats via the PI3K/AKT Pathway.
11/2020	Pea-derived peptides, VLP, LLP, VA, and LL, improve insulin resistance in HepG2 cells via activating IRS-1/PI3K/AKT and blocking ROS-mediated p38MAPK signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuchen Wang Research Topics

Disease

48	Neoplasms (Cancer) 04/2024 - 01/2014
16	Infections 01/2024 - 01/2017
8	Neoplasm Metastasis (Metastasis) 02/2023 - 01/2019
7	Inflammation (Inflammations) 03/2024 - 12/2017
5	Fibrosis (Cirrhosis) 12/2023 - 01/2017
4	Acute Kidney Injury (Acute Renal Failure) 04/2024 - 02/2017
4	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2021
4	Carcinoma (Carcinomatosis) 12/2023 - 05/2018
4	Hepatocellular Carcinoma (Hepatoma) 03/2021 - 10/2018
3	Obesity 12/2023 - 01/2019
3	Body Weight (Weight, Body) 12/2023 - 02/2021
3	Esophageal Neoplasms (Esophageal Cancer) 07/2023 - 01/2021
3	COVID-19 03/2023 - 01/2021
3	Hypoxia (Hypoxemia) 01/2023 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 04/2021 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2019
3	Zika Virus Infection 01/2021 - 01/2019
2	Ulcerative Colitis 03/2024 - 02/2021
2	Colitis 03/2024 - 12/2023
2	Hemorrhage 01/2024 - 11/2022
2	Pain (Aches) 01/2024 - 03/2016
2	Lung Neoplasms (Lung Cancer) 12/2023 - 10/2019
2	Dry Eye Syndromes (Dry Eye Syndrome) 12/2023 - 07/2022
2	Necrosis 12/2023 - 02/2020
2	Adenocarcinoma of Lung 12/2023 - 06/2018
2	Carcinogenesis 11/2023 - 02/2018
2	Viremia 11/2023 - 10/2022
2	Virus Diseases (Viral Diseases) 04/2023 - 01/2019
2	Radiation Injuries (Radiation Sickness) 03/2023 - 01/2018
2	Esophageal Squamous Cell Carcinoma 12/2022 - 01/2021
2	Rosacea (Acne Rosacea) 04/2022 - 02/2021
2	Disease Progression 01/2022 - 01/2021
2	Heart Failure 01/2022 - 01/2021
2	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2022 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2021
2	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 11/2020
2	Bites and Stings (Sting) 03/2020 - 01/2019
2	Pancreatitis 12/2019 - 11/2017
2	End Stage Liver Disease 11/2019 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2018 - 01/2017
2	Reperfusion Injury 01/2017 - 10/2016
2	Ascites 01/2017 - 01/2017
1	Pulmonary Edema 05/2024
1	Lung Injury 05/2024
1	Acute Lung Injury 05/2024

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2016
6	Long Noncoding RNAIBA 12/2023 - 01/2021
6	ProdrugsIBA 12/2023 - 01/2020
5	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 10/2019
5	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 01/2022
5	VaccinesIBA 10/2022 - 01/2019
4	Peptides (Polypeptides)IBA 11/2020 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2017
3	MicroRNAs (MicroRNA)IBA 12/2023 - 01/2022
3	Metformin (Glucophage)FDA LinkGeneric 10/2023 - 01/2019
3	protopanaxadiolIBA 01/2022 - 02/2018
3	LigandsIBA 01/2022 - 06/2013
3	GinsenosidesIBA 01/2022 - 11/2017
3	RutheniumIBA 11/2020 - 10/2019
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020 - 06/2013
2	PolyphenolsIBA 04/2024 - 01/2024
2	Dextran SulfateIBA 03/2024 - 02/2021
2	CreatinineIBA 01/2024 - 12/2019
2	Uric Acid (Urate)IBA 01/2024 - 06/2022
2	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2021
2	Tumor Viral Antigens (Large T Antigen)IBA 11/2023 - 01/2021
2	Therapeutic UsesIBA 10/2023 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2023 - 11/2021
2	AntioxidantsIBA 07/2023 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 04/2023 - 02/2019
2	AntibodiesIBA 03/2023 - 01/2021
2	Immune Sera (Antisera)IBA 08/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	ginsenoside M1IBA 01/2022 - 01/2021
2	NanogelsIBA 01/2022 - 01/2021
2	Programmed Cell Death 1 ReceptorIBA 01/2022 - 01/2021
2	Opioid Analgesics (Opioids)IBA 01/2022 - 03/2016
2	EsterasesIBA 04/2021 - 01/2021
2	Docetaxel (Taxotere)FDA Link 01/2021 - 09/2012
2	cabazitaxel FDA Link 01/2021 - 10/2020
2	AlbuminsIBA 01/2021 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2020 - 10/2016
2	EnzymesIBA 06/2019 - 02/2018
2	Tuberculin (PPD)IBA 01/2019 - 02/2018
1	LipopolysaccharidesIBA 05/2024
1	chelerythrineIBA 03/2024

Therapy/Procedure

33	Therapeutics 02/2024 - 07/2011
4	Immunotherapy 01/2022 - 01/2021
3	Oral Administration 12/2023 - 12/2022
3	Kidney Transplantation 11/2023 - 01/2017
3	Drug Therapy (Chemotherapy) 03/2023 - 10/2018
3	Length of Stay 01/2021 - 11/2017
2	Neoadjuvant Therapy 04/2024 - 04/2021
2	Liver Transplantation 06/2023 - 01/2019
2	Radiotherapy 03/2023 - 12/2022
2	Intravenous Administration 02/2023 - 01/2020
2	Resuscitation 01/2022 - 01/2019
2	Transplantation 01/2020 - 01/2017
1	Treatment Delay 04/2024